Dual-specificity phosphatases: therapeutic targets in cancer therapy resistance
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00432-021-03874-2.pdf
Reference149 articles.
1. Aesoy R et al (2008) An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells. Mol Cancer Res 6(10):1630–1638
2. Alexandre J et al (2007) Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species. Can Res 67(8):3512–3517
3. Alonso A et al (2004) Protein tyrosine phosphatases in the human genome. Cell 117(6):699–711
4. Arora D et al (2012) Expression of protein-tyrosine phosphatases in acute Myeloid Leukemia cells: FLT3 ITD sustains high levels of DUSP6 expression. Cell Commun Signal 10(1):1–15
5. Bagnyukova TV et al (2013) DUSP6 regulates drug sensitivity by modulating DNA damage response. Br J Cancer 109(4):1063–1071
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. CCR7/DUSP1 signaling Axis mediates iCAF to regulates head and neck squamous cell carcinoma growth;Cellular Signalling;2024-10
2. Dynamic and structural insights into allosteric regulation on MKP5 a dual-specificity phosphatase;2024-09-05
3. DUSP8-attenuated ERK1/2 signaling mediates lipogenesis and steroidogenesis in chicken granulosa cells;Theriogenology;2024-09
4. Upregulation of hsa-miR-141-3p promotes uterine cervical carcinoma progression via targeting dual-specificity protein phosphatase 1;Functional & Integrative Genomics;2024-08
5. DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer;EMBO Molecular Medicine;2024-06-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3